🚀 VC round data is live in beta, check it out!
JETEMA Co. Valuation Multiples
Discover revenue and EBITDA valuation multiples for JETEMA Co. and similar public comparables like Sisram Medical, 908 Devices, MTI Ltd., Carvolix and more.
JETEMA Co. Overview
About JETEMA Co.
JETEMA Co Ltd is a bio venture company. It offers products such as Botulinum toxin, Filler, Anti-aging solutions. The company also offers medical devices and cosmetics.
Founded
2009
HQ
Employees
N/A
Website
Financials (FY)
EV
$313M
JETEMA Co. Financials
JETEMA Co. reported last fiscal year revenue of $51M and EBITDA of $8M.
In the same fiscal year, JETEMA Co. generated $24M in gross profit, $8M in EBITDA, and had net loss of ($4M).
Revenue (LTM)
JETEMA Co. P&L
In the most recent fiscal year, JETEMA Co. reported revenue of $51M and EBITDA of $8M.
JETEMA Co. expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $51M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $24M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 48% | XXX | XXX | XXX |
| EBITDA | — | XXX | $8M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 15% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 5% | XXX | XXX | XXX |
| Net Profit | — | XXX | ($4M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (9%) | XXX | XXX | XXX |
| Net Debt | — | — | $74M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
JETEMA Co. Stock Performance
JETEMA Co. has current market cap of $243M, and enterprise value of $313M.
Market Cap Evolution
JETEMA Co.'s stock price is $6.76.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $313M | $243M | 0.1% | XXX | XXX | XXX | $-0.12 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialJETEMA Co. Valuation Multiples
JETEMA Co. trades at 6.1x EV/Revenue multiple, and 41.3x EV/EBITDA.
EV / Revenue (LTM)
JETEMA Co. Financial Valuation Multiples
As of April 8, 2026, JETEMA Co. has market cap of $243M and EV of $313M.
Equity research analysts estimate JETEMA Co.'s 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
JETEMA Co. has a P/E ratio of (55.4x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $243M | XXX | $243M | XXX | XXX | XXX |
| EV (current) | $313M | XXX | $313M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 6.1x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 41.3x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 123.7x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 12.8x | XXX | XXX | XXX |
| P/E | — | XXX | (55.4x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (98.5x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified JETEMA Co. Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
JETEMA Co. Margins & Growth Rates
JETEMA Co.'s revenue in the last fiscal year grew by 12%.
JETEMA Co. Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 12% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 15% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (26%) | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 9% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 3% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 13% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 43% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
JETEMA Co. Public Comps
See public comps and valuation multiples for other Health & Beauty and Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Sisram Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| 908 Devices | XXX | XXX | XXX | XXX | XXX | XXX |
| MTI Ltd. | XXX | XXX | XXX | XXX | XXX | XXX |
| Carvolix | XXX | XXX | XXX | XXX | XXX | XXX |
| Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
JETEMA Co. M&A Activity
JETEMA Co. acquired XXX companies to date.
Last acquisition by JETEMA Co. was on XXXXXXXX, XXXXX. JETEMA Co. acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by JETEMA Co.
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialJETEMA Co. Investment Activity
JETEMA Co. invested in XXX companies to date.
JETEMA Co. made its latest investment on XXXXXXXX, XXXXX. JETEMA Co. invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by JETEMA Co.
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout JETEMA Co.
| When was JETEMA Co. founded? | JETEMA Co. was founded in 2009. |
| Where is JETEMA Co. headquartered? | JETEMA Co. is headquartered in South Korea. |
| Is JETEMA Co. publicly listed? | Yes, JETEMA Co. is a public company listed on Korea Exchange. |
| What is the stock symbol of JETEMA Co.? | JETEMA Co. trades under 216080 ticker. |
| When did JETEMA Co. go public? | JETEMA Co. went public in 2019. |
| Who are competitors of JETEMA Co.? | JETEMA Co. main competitors are Sisram Medical, 908 Devices, MTI Ltd., Carvolix. |
| What is the current market cap of JETEMA Co.? | JETEMA Co.'s current market cap is $243M. |
| What is the current revenue of JETEMA Co.? | JETEMA Co.'s last fiscal year revenue is $51M. |
| What is the current EV/Revenue multiple of JETEMA Co.? | Current revenue multiple of JETEMA Co. is 6.1x. |
| Is JETEMA Co. profitable? | No, JETEMA Co. is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.